The relationship between chronic obstructive pulmonary disease (COPD ... including diagnostic criteria and management of acute exacerbation of CB (AECB) in the elderly patient.

Cardiopulmonary risk has recently been proposed and is defined as: The risk of serious and/or cardiovascular events in ...

在慢性阻塞性肺疾病（COPD）患者中，吞咽障碍增加了患者发生吸入性肺炎和急性加重的风险。研究人员开展了吞咽和呼吸感觉评估（SwaRSA）测试及吞咽康复干预的成本效益研究。结果显示，EAT-10 等测试及干预具有成本效益，这为临床制定干预策略提供了经济依据。

Decreased levels of resolvin D1 are linked to prolonged respiratory symptoms and slower clinical recovery in patients with ...

Researchers sought to determine the effect of COPD exacerbation risk for ASCVD hospitalization in patients with ASCVD.

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Epinephrine is not recommended as a substitute for prescription SABAs, which are the gold standard for treating acute COPD exacerbations. These include: In 2011, Primatene Mist was pulled from the ...

The study highlighted the significant benefits of long-term oxygen therapy in reducing total and hospitalized acute ...

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

“We are on track to initiate parallel Phase 2 trials of rademikibart as an adjunct to standard of care for the treatment of acute asthma and COPD exacerbations in the second quarter of ...